Breaking News

PPD Appoints Corporate Development SVP

April 22, 2014

De Silva brings 15 years of biopharma experience

Bhooshi De Silva has been appointed senior vice president of corporate development and strategy at PPD, and joins the executive leadership team. Mr. De Silva will focus on key strategic initiatives to support growth, including corporate development, strategy and mergers and acquisitions.
 
Mr. De Silva has 15 years of experience in the biopharma industry and has served in leadership roles. He began his career at Pfizer, serving in roles across the R&D and commercial organizations in portfolio management, strategy and operations. His responsibilities included overseeing the development and strengthening of analytical frameworks and decision-making processes. Most recently, he served as head of business development, corporate strategy and international teams at Optimer Pharmaceuticals.
 
“Bhooshi’s vision and expertise will be invaluable in our efforts to grow our business and successfully meet the evolving needs of our clients,” said David Simmons, PPD’s chairman and chief executive officer. “He comes to PPD well-prepared to help us navigate the challenges of the changing biopharmaceutical landscape, while developing and executing a strategy for our company’s continued success.”
  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks